van Ede noted that elevated alanine transaminase (ALT) values led to MTX discontinuation in only 11 (4.0%) of 274 patients on folic acid or folinic acid compared to 35 (25.5%) of 137 RA patients who did not receive folic acid [22]. The gene discussed is GPT; the disease is rheumatoid arthritis.